The Coexistence of the Fibromyalgia Syndrome and the Overactive Bladder Syndrome

REFERENCES

• Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmstein U. The standardisation of terminology in lower tract function: report from the standardization subcommitee of the International Continence Society. Urology 2003; 61: 37
   PubMed Web of Science ®Google Scholar
• Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ. Prevalance and burden of overactive. World J Urol 2003; 20(6)327–336
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the multicenter criteria committee. Arthritis Rheum 1990; 33: 160–172
   PubMed Web of Science ®Google Scholar
• Goldenberg DL. Fibromyalgia and related syndromes. Rheumatology, JH Klippel, PA Dieppe. Mosby, Philadelphia 1998; 1–12
   Google Scholar
• Clauw DJ. Musculoskeletal pain and evaluation. Kelley's Textbook of Rheumatology, S uddy, ED Haris, CB Sledge. WB Saunders Company, Philadelphia 2001; 417–427
   Google Scholar
• Russell IJ, Vaerøy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amine metabolities in fibro-myalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992; 35: 550
   PubMed Web of Science ®Google Scholar
• Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC. Plasma tryptophan and other aminoacids in primary fibromyalgia: A controlled study. J Rheum 1992; 19: 90–94
   PubMed Web of Science ®Google Scholar
• Cornelissen LL, Brooks DP, Wibberley A. Female, but not male, serotonin reuptake transporter (5-HTT) knockout mice exhibit bladder instability. Autonomic Neuroscience: Basic and Clinical 2005; 122(1–2)107–110
   PubMed Web of Science ®Google Scholar
• Maggi CA, Meli A: Reserpine-induced detrusor hyperreflexia. an in vivo model for studying smooth muscle relaxants at urinary bladder level. J. Pharmacol. Methods 1983; 10: 79–91
   PubMedGoogle Scholar
• Sugaya K, Ogawa Y, Hatano T, Koyama Y, Miyazato T, Oda M. Evidence for involvement of the subcoeruleus nucleus and nucleus raphe magnus in urine storage and penile erection in decerebrate rats. J Urol 1998; 159: 2172–2176
   PubMed Web of Science ®Google Scholar
• Nielsen AC, Williams TA. Depression in ambulatory medical patients prevalence by self report questionnaire and recognition by nonpsychiatric physicians. Arch Gen Psych 1980; 37: 999–1004
   PubMed Web of Science ®Google Scholar
• Ford APDW, Kawa MS. 5 HT 4 receptors in lower tract tissues. 5 HT4 receptors in brain and periphery, R glen. Landes Bioscience Publications, Texas 1997; 76–80
   Google Scholar
• De Groat WC. Influence of central serotonergic mechanisms on lower urinary tract function. Urology 2002; 59(5 Suppl 1)30–36
   PubMed Web of Science ®Google Scholar
• Skagerberg G, Bjorklund A. Topographic principles in the spinal projections of serotonergic and non-serotonergic brainstem neurons in the rat. Neuroscience 1985; 15: 445–480
   PubMed Web of Science ®Google Scholar
• Kojima M, Takeuchi Y, Goto M, Sano Y. Immunohistochemical study on the localization of serotonin fibers and terminals in the spinal cord of the monkey (Macaca fuscata). Cell Tissue Res 1983; 229: 23–36
   PubMed Web of Science ®Google Scholar
• Marlier L, Teilhac JR, Cerruti C, Pricate A. Autoradiographic mapping of 5-HT1, 5-HT1A, 5-HT1B, and 5-HT2 receptors in the rat spinal cord. Brain Res 1991; 550: 15–23
   PubMed Web of Science ®Google Scholar
• Thor KB, Nickolaus S, Helke CJ. Autoradio-graphic localization of 5-hydroxytryptamine1A, 5-hydroxy-tryptamine1B and 5-hydroxytryptamine1C/2 binding sites in the rat spinal cord. Neuroscience 1993; 55: 235–252
   PubMed Web of Science ®Google Scholar
• Helton L, Thor KB, Baez M. 5-Hydroxytryp-tamine2A, 5-hydroxytryptamine2B, and 5-hydroxytryp-tamine2C receptor mRNA expression in the spinal cord of rat, cat, monkey, and human. Neuroreport 1995; 5: 2617–2620
   Web of Science ®Google Scholar
• Neeck GA. Pathogenic mechanisms of fibro-myalgia. Aging Res Rev 2002; 1(2)243–255
   PubMed Web of Science ®Google Scholar
• Wolfe F, Russell IJ, Vipraio G, Ross K, Anderson J. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol 1997; 24(3)555–559
   PubMed Web of Science ®Google Scholar
• Zorn BH, Montgomery H, Pieper K, Gray M, Steers WD. Urinary incontinence and depression. J Urol 1999; 162(1)82–84
   PubMed Web of Science ®Google Scholar
• Masand PS, Kaplan DS, Gupta S, Bhandary AN, Nasra GS, Kline MD, Margo KL. Major depression and irritable bowel syndrome: is there a relationship?. J Clin Phychiatry 1995; 56: 363–367
   PubMed Web of Science ®Google Scholar
• Cukier JM, Cortina-Borja M, Crawley JN. A case-control study to examine any association between idiopathic detrusor instability and gastrointestinal tract disorder, and between irritable bowel syndrome and urinary tract disorder. Br J Urol 1997; 79(6)865–78
   PubMedGoogle Scholar
• Veale D, Kavanagh G, Fielding JF, Fitzgerald O. Primary fibromyalgia and the irritable bowel syndrome: Different expressions of a common pathogenetic process. Br J Rheumatol 1991; 30(3)220–222
   PubMedGoogle Scholar
• Whitehead WE, Bosmajian L, Zonderman AB, Costa PT, Jr, Schuster MM. Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology 1988; 95(3)709–714
   Google Scholar
• Ozgocmen S, Ozyurt H, Sogut S, Akyol O. Current concept in the pathophysiology of fibromyalgia: the potential role of oxidative stres and nitric oxide. Rheumatol Int 2006; 26: 585–597
   PubMed Web of Science ®Google Scholar
• Uckert S, Stief CG, Lietz B, Burmester M, Jonas U, Machtens SA. Possible role of bioactive peptides in the regulation of human detrusor smooth muscle-functional effects in vitro and immunohistochemical presence. World J Urol 2002; 20(4)244–249
   PubMed Web of Science ®Google Scholar
• Pache M, Ochs J, Genth E, Mierau R, Kube T, Flammer J. Increased plasma endothelin-1 levels in fibromyalgia syndrome. Rheumatology (Oxford) 2003; 42(3)493–494
   PubMed Web of Science ®Google Scholar
• Hedenberg-Agnusson B, Ernberg M, Alstergren P, Kopp S. Pain mediation by prostaglandin E2 and leukotriene B4 in the human masseter muscle. Acta Odontol Scand 2001; 59(6)348–355
   PubMed Web of Science ®Google Scholar
• Azadzoi KM, Shinde VM, Tarcan T, Kozlowski R, Siroky MB. Increased leukotriene and prostaglandin release, and overactivity in the chronically ischemic bladder. J Urol 2003; 169(5)1885–1891
   PubMed Web of Science ®Google Scholar
• Andersson KE, Wein AJ. Pharmacology of the lower urinary tract: Basis for current and future treatments of urinary incontinence. Pharmacol Rev 2004; 56: 581–631
   PubMed Web of Science ®Google Scholar
• Hoa MH, Bhatiaa NN, Khorram O. Physiologic role of nitric oxide and nitric oxide synthase in female lower urinary tract. Curr Opin Obstet Gynecol 2004; 16: 423–429
   PubMed Web of Science ®Google Scholar
• Araki I, De Groat WC. Unitary excitatory synaptic currents in preganglionic neurons mediated by two distinct groups of interneurons in neonatal rat sacral parasympathetic nucleus. J Neurophysiol 1996; 76: 215–226
   PubMed Web of Science ®Google Scholar
• De Groat WC, Downie JW, Levin RM, Long Lin AT, Morrison JFB, Nishizawa O, Steers WD, Thor KB. Basic neurophysiology and neuropharmacology, Incontinence, P Abrams, S Khoury, A Wein. Plymbridge Distributors Ltd, PlymouthUK 1999; 105–154
   Google Scholar
• Matsumoto G, Hisamitsu T, de Groat WC. Role of glutamate and NMDA receptors in the descending limb of the spinobulbospinal micturition reflex pathway of the rat. Neurosci Lett 1995; 183: 58–61
   PubMed Web of Science ®Google Scholar
• Bennett R. Fibromyalgia, chronic fatigue syndrome, and myofascial pain. Curr Opin Rheumatol 1998; 10(2)95–103
   PubMedGoogle Scholar
• Ishizuka O, Igawa Y, Lecci A, Maggi CA, Mattiasson A, Andersson KE. Role of intrathecal tachykinins for micturition in unanaesthetized rats with and without bladder outlet obstruction. Br J Pharmacol 1994; 113: 111–116
   PubMed Web of Science ®Google Scholar
• Seki S, Erickson KA, Sasaki K, Sugaya K, Chancellor MB, de Groat WC, Yoshimura N. Effect of intrathecal substance P-saponin conjugate on bladder hyperactivity induced by intravesical capsaicin. SFN 32nd Annual Meeting, Orlando, FL. Society for Neuroscience, Washington, DC November 2–7, 2002, Program No 68.2
   Google Scholar
• Russell IJ, Litmann B. Elevated cerebrospinal fluid levels of substance-P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994; 37: 1593–1601
   PubMed Web of Science ®Google Scholar
• Cowen PJ. Serotonin receptor subtypes in depression: evidence from studies in neuroendocrine regulation. Clin Neuropharmacol 1993; 16(Suppl 3)6–18
   Google Scholar
• Lesch KP. 5-HT1A receptor responsivity in anxiety disorders and depression. Prog. Neuro-Psycho-pharmacol. Biol Psychiat 1991; 15: 723–733
   PubMed Web of Science ®Google Scholar
• Steers WD. Physiology and pharmacology of the bladder and urethra. Campbell's Urology, PC Walsh, AB Retik, ED Vaughan, AJ Wein. WB Saunders, Philadelphia 1998; 870–915
   Google Scholar
• Tubaro A. Defining overactive bladder: Epidemiology and burden of disease. Urology 2004; 64(6 Suppl 1)2–6
   PubMed Web of Science ®Google Scholar